Literature DB >> 11781841

Recruitment of TRRAP required for oncogenic transformation by E1A.

L Deleu1, S Shellard, K Alevizopoulos, B Amati, H Land.   

Abstract

TRRAP links Myc with histone acetylases and appears to be an important mediator of its oncogenic function. Here we show that interaction with TRRAP is required for cellular transformation not only by Myc, but also by the adenovirus E1A protein. Substitution of the 262 N-terminal residues of Myc with a small domain of E1A (residues 12-54) restores Myc transforming function. E1A(12-54) contains a TRRAP-interaction domain, that recruits TRRAP to either E1A-Myc chimeras, or the native 12S E1A protein. Overexpression of a competing TRRAP fragment in vivo blocks interaction of cellular TRRAP with either E1A-Myc or E1A, and suppresses cellular transformation by both oncoproteins. Moreover, E1A(Delta26-35) that fails to bind TRRAP but is capable of binding the Retinoblastoma (Rb)-family and p300/CBP proteins is defective in cellular immortalization, transformation and cell cycle deregulation. Thus in addition to disrupting Rb and p300/CBP functions, E1A must recruit TRRAP to transform cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781841     DOI: 10.1038/sj.onc.1205159

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.

Authors:  S Vijayalingam; T Subramanian; Ling-Jun Zhao; G Chinnadurai
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

2.  E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase.

Authors:  Jingfeng Sha; Mrinal K Ghosh; Keman Zhang; Marian L Harter
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

3.  Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc.

Authors:  Kathryn A Tworkowski; Abhishek A Chakraborty; Andrew V Samuelson; Yvette R Seger; Masako Narita; Gregory J Hannon; Scott W Lowe; William P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

Review 4.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

5.  The p400 E1A-associated protein is a novel component of the p53 --> p21 senescence pathway.

Authors:  Ho Man Chan; Masako Narita; Scott W Lowe; David M Livingston
Journal:  Genes Dev       Date:  2005-01-15       Impact factor: 11.361

6.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

7.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

Review 9.  SGF29 and Sry pathway in hepatocarcinogenesis.

Authors:  Nobuya Kurabe; Shigekazu Murakami; Fumio Tashiro
Journal:  World J Biol Chem       Date:  2015-08-26

10.  TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins.

Authors:  Mikhail A Nikiforov; Sanjay Chandriani; Jeonghyeon Park; Iulia Kotenko; Dina Matheos; Anna Johnsson; Steven B McMahon; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.